Paper · 4362000
Augmentation of cytotoxic drug action by antibodies directed at cell surface.
Rubens RD and 1 other. Nature, 1974. Cited by 59 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Augmentation of cytotoxic drug action by antibodies directed at cell surface. Papers, record 4362000. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4362000
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neoplasm | Major topic |
| Cell Division | Major topic |
| Chlorambucil | Major topic |
| Animals | |
| Cell Line | |
| Cell Transformation, Neoplastic | |
| Chromium Radioisotopes | |
| Clone Cells | |
| Cytotoxicity Tests, Immunologic | |
| Immune Sera | |
| Kidney | |
| Mice | |
| Polyomavirus |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,374,229 | Immunological aspects of trophoblastic neoplasia. | Br J Cancer Suppl | 1973 | https://conductscience.org/library/papers/4374229 | PubMed |
| 2 | 5,404,005 | Adsorption to human red blood cells of chlorambucil and other biological alkylating agents. | Biochem Pharmacol | 1969 | https://conductscience.org/library/papers/5404005 | PubMed |
| 3 | 4,553,765 | Antibody as carrier of chlorambucil. | Cancer | 1972 | https://conductscience.org/library/papers/4553765 | PubMed |
| 4 | 14,278,870 | SOME OBSERVATIONS ON THE REACTIONS OF CHLORAMBUCIL, AZO-MUSTARD (CB 1414), AND CYCLOPHOSPHAMIDE. | Proc Can Cancer Conf | 1963 | https://conductscience.org/library/papers/14278870 | PubMed |
| 5 | 4,986,716 | Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells. | Science | 1970 | https://conductscience.org/library/papers/4986716 | PubMed |
| 7 | 4,560,726 | Immunochemotherapy of cancer with chlorambucil-carrying antibody. | Br Med J | 1972 | https://conductscience.org/library/papers/4560726 | PubMed |
| 8 | 6,015,636 | Immunoradioactive agent against cancer. | Br Med J | 1967 | https://conductscience.org/library/papers/6015636 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27,518,975 | Histochemical effects of the proteolytic enzyme brinase on ascites tumour cells. | Ir J Med Sci | 1975 | https://conductscience.org/library/papers/27518975 | PubMed |
| 6,988,099 | Oncostatic-antibody complexes in chemotherapy. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/6988099 | PubMed |
| 6,809,124 | Immune guided missiles. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6809124 | PubMed |
| 3,527,466 | Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3527466 | PubMed |
| 2,418,949 | In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/2418949 | PubMed |
| 1,233,080 | Augmentation of cytotoxic drug action and X-irradiation by antibodies. | Br J Cancer | 1975 | https://conductscience.org/library/papers/1233080 | PubMed |
| 1,174,447 | Aggregation of chlorambucil in vitro may cause misinterpretation of protein binding data. | Br J Cancer | 1975 | https://conductscience.org/library/papers/1174447 | PubMed |
| 856,027 | Measurement of polyene antibiotic-mediated erythrocyte damage by release of hemoglobin and radioactive chromium. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/856027 | PubMed |
| 834,290 | Targeting of drugs. | Nature | 1977 | https://conductscience.org/library/papers/834290 | PubMed |
| 625,344 | Toxicity of diphtheria toxin for lymphoblastoid cells is increased by conjugation to antilymphocytic globulin. | Nature | 1978 | https://conductscience.org/library/papers/625344 | PubMed |
1 to 10 of 12
See all 12 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4362000
GET https://conductscience.org/api/papers/v1/4362000/authors